跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DBL PENTAMIDINE ISETHIONATE 300mg powder for injection - TGA Drug Approval Details
Approvals
/
TGA
/
DBL PENTAMIDINE ISETHIONATE 300mg powder for injection
Approved
STANDARD
DBL PENTAMIDINE ISETHIONATE 300mg powder for injection
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
70a3eabb4bf6fcfd
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
70a3eabb4bf6fcfd
Product Name
DBL PENTAMIDINE ISETHIONATE 300mg powder for injection
Artg Id
16260
Artg Name
DBL PENTAMIDINE ISETHIONATE 300mg powder for injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
1991-10-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/5109d4abf11135ad1f6fef5b5935ae57.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/01e15eee2b4f54b8f78cfc7ac9448140.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
70a3eabb4bf6fcfd
Type
Standard
Back to TGA Approvals